Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 21;19(27):4356-62.
doi: 10.3748/wjg.v19.i27.4356.

Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate

Anna Wiernicka  1 , Wojciech Jańczyk, Maciej Dądalski, Yesim Avsar, Hartmut Schmidt, Piotr Socha
Affiliations

Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate

Anna Wiernicka et al. World J Gastroenterol. .

Abstract

Aim: To investigate the side effects of a zinc sulphate therapy in a cohort of Polish pediatric patients with Wilson's disease.

Methods: We retrospectively analyzed a cohort of 53 pediatric patients with Wilson's disease treated at the Children's Memorial Health Institute in Warsaw, Poland between the years 1996 and 2011 with zinc sulphate. Patients were diagnosed with Wilson's disease according to the scoring system of Ferenci, with 49 cases confirmed by mutation analysis. Data about the dosage scheme of zinc sulphate, side effects and efficacy and toxicity of the treatment were collected and recorded in the patient's medical chart at each visit to the hospital.

Results: Mean age of diagnosis for the entire cohort was 10 years (range, 2.5-17 years). Duration of treatment with zinc sulfate was 83.3 wk (range, 8-344 wk). Side effects, all of gastrointestinal origin, were observed in 21 patients (40%--9 males and 12 females), irrespective of the duration of therapy. Thirteen out of 21 patients were over the age of 10 years. The most common ATP7B mutation was p.H1069Q. Esophagogastroduodenoscopy, performed in 7 patients (33.3%) suffering from persistent and severe abdominal pain, revealed gastrointestinal ulcerations or erosions with negative Helicobacter pylori tests in all subjects investigated. The above mentioned 7 patients were treated with proton pump inhibitors. Three of those experienced resolution of symptoms, whereas proton-pump inhibitors failed to alleviate symptoms of the remaining four children and conversion of therapy to D-penicillamine was needed.

Conclusion: Zinc sulphate appears to cause significant gastrointestinal side effects, which children on therapy for Wilson's disease should be closely monitored for.

Keywords: Abdominal pain; Gastrointestinal ulcer; Therapy; Wilson’s disease; Zinc.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Endoscopic image. A: Endoscopic image of patient 6. Deep ulcer on the minor curvature of the stomach; B: Endoscopic image of patient 1. Flat mucosal ulcerations of the greater curvature of the stomach, about 1 cm in diameter covered with a flat fibrous coating.
See this image and copyright information in PMC

References

    1. Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51:225–227. - PubMed
    1. Hoffman HN, Phyliky RL, Fleming CR. Zinc-induced copper deficiency. Gastroenterology. 1988;94:508–512. - PubMed
    1. Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA. 1990;264:1441–1443. - PubMed
    1. Yuzbasiyan-Gurkan V, Brewer GJ, Abrams GD, Main B, Giacherio D. Treatment of Wilson’s disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson’s disease. J Lab Clin Med. 1989;114:520–526. - PubMed
    1. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V. Treatment of Wilson’s disease with zinc. IX: Response of serum lipids. J Lab Clin Med. 1991;118:466–470. - PubMed

Publication types

MeSH terms